Skip to main content

Table 2 Care provided in the ICU

From: Long-term survival after intensive care for COVID-19: a nationwide cohort study of more than 8000 patients

Variable

All (n = 8392)

Women (n = 2509)

Men (n = 5883)

P-value

Highest level of respiratory support

 No. with data

8326

2495

5831

 

 Invasive mechanical ventilation, No. (%)

5288 (63.5)

1493 (59.8)

3795 (65.1)

< 0.001

 Non-invasive mechanical ventilation, No. (%)

1371 (16.5)

448 (18)

923 (15.8)

 

Duration of invasive mechanical ventilation

 No. with data

5288

1493

3795

 

 Median (IQR), d

10.9 (5.8–19.7)

9.5 (4.9–17.4)

11.6 (6.0–20.7)

< 0.001

 Renal replacement therapy, No./total (%)

837/7121 (11.8)

183/2168 (8.4)

654/4953 (13.2)

< 0.001

 Prone position, No./total (%)

3565/7625 (46.8)

963/2305 (41.8)

2602/5320 (48.9)

< 0.001

 ECMO, No./total (%)

57/4446 (1.3)

16/1324 (1.2)

41/3122 (1.3)

0.890

 Tracheostomy, No./total (%)

1842/8313 (22.2)

452/2492 (18.1)

1390/5821 (23.9)

< 0.001

 One or more readmissions, No. (%), a

2133 (25.4)

573 (22.8)

1560 (26.5)

< 0.001

 ICU length of stay, median (IQR), d

9.0 (3.6–18.0)

7.6 (2.8–15.1)

9.6 (3.9–19.0)

< 0.001

Outcome No/total (%)

 30-day mortality

2065/8392 (24.6)

581/2509 (23.2)

1484/5883 (25.2)

0.047

 90-day mortality

2434/8329 (29.2)

671/2487 (27.0)

1763/5842 (30.2)

0.004

 180-day mortality

2449/8239 (29.7)

668/2455 (27.2)

1781/5784 (30.8)

0.001

 360-day mortality

2206/7390 (29.9)

590/2175 (27.1)

1616/5215 (31.0)

0.001

  1. IQR interquartile range, a Includes readmission and transfers between ICUs, d days, ECMO extracorporeal membrane oxygenation, ICU intensive care unit